SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing heavy community interest following an SEC filing that updated executive change-of-control agreements, which investors are interpreting as a signal that the company is positioning for an imminent buyout. This speculation is amplified by a high-pressure environment for shorts, characterized by surging borrow fees and constrained share availability, as traders prepare for the long-anticipated unblinding of the REGAL trial's 80th event.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for retail investors, with intense community debate over whether it serves as a legitimate undervalued buyout candidate or a high-risk squeeze play. Discussions are driven by heavy short interest and significant intraday volatility, as bulls advocate for buying the dip while bears highlight concerns regarding debt and market-wide sell-offs.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging as investors react to a blockbuster quarterly earnings report that significantly surpassed expectations and highlighted the company's critical role in the AI infrastructure supply chain. The community is heavily focused on newly secured, long-term customer agreements that suggest memory is shifting from a cyclical commodity to a core structural pillar of AI demand, prompting a flurry of aggressive analyst price target hikes.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is facing significant market pressure as chip supply shortages lead to product price hikes, sparking concerns about potential demand destruction and margin erosion. Investors are closely monitoring the stock's support levels as the community debates whether the AI-driven hardware cycle is a bullish long-term catalyst or a signal of broader inflationary risk.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is currently experiencing heightened volatility and significant volume spikes, driven by unconfirmed market chatter regarding a potential acquisition and speculative interest in biotech sector rotation. While some investors remain skeptical due to recurring historical price stagnation, others are betting on heavy upside through aggressive call option accumulation as the stock tests key resistance levels.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The Dow is trending as it hits new record highs, fueled by intense investor focus on upcoming Federal Reserve policy shifts and the potential conclusion of the U.S.-Iran conflict. Market participants are actively debating the sustainability of this rally given the significant divergence between index performance and underlying economic indicators, while closely monitoring the highly anticipated IPO of SpaceX as a bellwether for market appetite.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing heavy downward pressure as retail investors grapple with technical support breakdowns and broader sector-wide volatility. The community is sharply divided, with bulls viewing the pullback as a generational buying opportunity while vocal bears point to cooling AI sentiment and institutional distribution.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a fiscal quarter earnings beat, revenue growth, and raised guidance, alongside significant community anticipation for the upcoming AGM. While the company's QNX software and Physical AI positioning fuel bullish sentiment, discussions are dominated by active debates between long-term supporters expecting a major turnaround and those skeptical of the firm's growth trajectory.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is experiencing a tug-of-war between strong relative momentum at all-time highs and deep investor skepticism ahead of the Fed's policy decision. The community remains divided, with bulls pointing to the strength of small-cap rotation as a sign of economic health, while bears are actively betting on a reversal, citing the index's vulnerability to potential rate hikes.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as investors react to its direct correlation with Bitcoin's recent price decline and mounting fears regarding corporate dilution. The stock remains a primary battleground between bulls anticipating a long-term turnaround fueled by institutional adoption and bears focused on potential liquidity risks and structural concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EQRX / $CMLS III $7.25 million investor settlement: deadline passed but late claims ARE still open 
 
If you held CMLS III Class A shares between December 14, 2021 and December 17, 2021, you may be eligible, even though the original deadline has passed. 
 
What happened? 
Investors alleged that CMLS III made misleading statements about its merger with Legacy EQRx that discouraged shareholders from exercising their redemption rights. After the merger closed, many investors who stayed invested experienced significant losses. 
 
Investors sued, and a $7.25 million settlement was finalized in January 2026. 
 
File your claim: https://11th.com/cases/cmlsiii-investor-settlement

CM Life Sciences III ("CMLS III") now EQRx, ("New EQRx") has agreed to a $7.25M settlement with former CMLS III Class A stockholders to resolve claims relate...

11th.com

CM Life Sciences III (CMLS III) now EQRx ($EQRx) $7.25M Investor Settlement

StockTwits Web

EQRx Inc

Cumulus Media Inc. - Ordinary Shares - Class A

 III $7.25 million investor settlement: deadline passed but late claims ARE still open 
 
If you held CMLS III Class A shares between December 14, 2021 and December 17, 2021, you may be eligible, even though the original deadline has passed. 
 
What happened? 
Investors alleged that CMLS III made misleading statements about its merger with Legacy EQRx that discouraged shareholders from exercising their redemption rights. After the merger closed, many investors who stayed invested experienced significant losses. 
 
Investors sued, and a $7.25 million settlement was finalized in January 2026. 
 
File your claim: 